The impact of biology on the treatment of secondary AML. [electronic resource]
Producer: 20020520Description: 231-55 p. digitalISSN:- 0927-3042
- Acute Disease
- Angiogenesis Inhibitors -- therapeutic use
- Animals
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Agents, Alkylating -- adverse effects
- Chromosome Deletion
- Chromosomes, Human, Pair 11 -- genetics
- Chromosomes, Human, Pair 7 -- genetics
- DNA Methylation
- DNA-Binding Proteins -- genetics
- Enzyme Inhibitors -- adverse effects
- Forecasting
- Genes, Tumor Suppressor
- Hematopoietic Stem Cells -- drug effects
- Histone Deacetylase Inhibitors
- Histone-Lysine N-Methyltransferase
- Humans
- Leukemia, Experimental -- etiology
- Leukemia, Myeloid -- chemically induced
- Leukemia, Radiation-Induced -- pathology
- Mice
- Mice, Inbred NOD
- Mice, SCID
- Myeloid-Lymphoid Leukemia Protein
- Neoplasm Proteins -- antagonists & inhibitors
- Neoplasms -- drug therapy
- Neoplasms, Second Primary -- chemically induced
- Neoplastic Stem Cells -- drug effects
- Neovascularization, Pathologic -- drug therapy
- Oncogene Proteins, Fusion -- genetics
- Proto-Oncogenes
- Stromal Cells -- pathology
- Topoisomerase II Inhibitors
- Transcription Factors
- Translocation, Genetic
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.